期刊文献+

他克莫司类脂质体凝胶体内外经皮渗透性研究 被引量:2

In vitro/vivo transdermal permeation of tacrolimus niosomes gel
下载PDF
导出
摘要 目的通过比较他克莫司(Tac)类脂质体(Tac-NS)凝胶、市售Tac软膏与普通凝胶的体内外经皮渗透性,阐明Tac-NS凝胶在提高Tac皮肤滞留量、延长药物释放的作用规律及特点。方法采用改良Franz扩散池进行离体猪皮渗透试验,以SD雄性大鼠为实验动物进行在体皮肤滞留研究,以LCMS/MS法测定接收液及皮肤中的Tac浓度,计算累积渗透量(Q)及皮肤滞留量(Q_(skin))。结果离体皮肤渗透试验中,Tac-NS凝胶在24 h内的Q_(skin)与Tac软膏相当(P>0.05),但明显高于普通凝胶(P<0.05);3种制剂的24 h累积渗透量(Q_(24))无明显差异(P>0.05)。大鼠在体皮肤滞留试验中,给药后8 h时的Tac-NS凝胶与Tac软膏Q_(skin)无明显差别(P>0.05),但12 h和24 h时,Tac-NS凝胶的Q_(skin)分别约为Tac软膏的2和2.5倍。结论 Tac-NS凝胶较普通(材料物理混合)凝胶可明显增加药物在离体及在体皮肤内的滞留量,与市售Tac软膏相比,Tac-NS能显著延长Tac在皮肤内的滞留时间,具有缓释作用。 Objective To compare the in vitro/vivo transdermal permeability of tacrolimus(Tac) niosomes(Tac-NS) gel, commercial Tac ointment and general gel, and to illuminate whether Tac-NS gel improves the retention and release of Tac. Methods Modified Franz diffusion cells were used in the in vitro transdermal permeation test. SD rats were used in the in vivo transdermal permeation test. The concentration of Tac in samples and skin was measured by LC-MS/MS. The cumulative penetration amounts(Q) and the cumulative retention amounts(Q_(skin)) were calculated. Results In the in vitro transdermal permeation test, the Q_(skin) of Tac-NS gel was similiar to that of Tac ointment(P 0.05) and higher than that of Tac-physical mixing gel(general gel)(P 0.05). Q_(24) of Tac-NS gel was a little lower than that of Tac ointment and Tac-materials mixing gel but with no difference(P 0.05). The in vivo transdermal permeation test showed that the Q_(skin) of Tac-NS and Tac ointment was similiar at 8 h. While the Q_(skin) of Tac-NS gel was 2 times and 2.5 times of that of Tac ointment at 12 h and 24 h(P 0.05), respectively. Conclusion Compared with Tac ointment, Tac-NS gel increases the drug retention in the skin, indicating a sustained drug release character.
出处 《中南药学》 CAS 2016年第8期823-826,共4页 Central South Pharmacy
关键词 他克莫司 类脂质体 凝胶剂 经皮渗透 皮肤滞留 tacrolimus niosomes gel transdermal permeation skin retention
  • 相关文献

参考文献9

  • 1Honbo T,Kobayashi M,Hane K,et al.The oral dosage form of FK-506[J].Transplant Proc,1987,19(5 Suppl6):17-22.
  • 2黄金沐,池慧琼,张忠阳.他克莫司的研究概况[J].海峡药学,2010,22(11):148-150. 被引量:15
  • 3吴娜,史爱欣,傅得兴.他克莫司软膏的药理及临床评价[J].药物不良反应杂志,2007,9(1):62-66. 被引量:18
  • 4Ference JD,Last AR.Choosing topical corticosteroids[J].Am Fam Physician,2009,79(2):135-140.
  • 5叶仕锋,陈日来,李玉珍,刘妮妮,刘君波,李红侠.他克莫司类脂囊泡的构建及表征[J].中国药房,2015,26(34):4853-4856. 被引量:5
  • 6Dai Y,Zhou R,Liu L,et al.Liposomes containing bile salts as novel ocular delivery systems for tacrolimus(FK506):in vitro characterization and improved corneal permeation[J].Int J Nanomedicine,2012,8(1):1921-1933.
  • 7Barbero AM,Frasch HF.Pig and guinea pig skin as surrogates for human in vitro penetration studies:a quantitative review[J].Toxicol In Vitro,2009,23(1):1-13.
  • 8杜喜平,广丰.类脂囊泡在皮肤局部的应用[J].中国化妆品,2008(4):94-96. 被引量:2
  • 9单瑞平,李永和,杜军,等.一种制备他克莫司软膏的方法:中国,CN201210356770.0[P].2013-01-23.

二级参考文献41

共引文献35

同被引文献14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部